Tocilizumab and Corticosteroids Increase Risk of COVID-19-Associated Pulmonary Aspergillosis Development Among Critically Ill Patients.

Awad, Mohammed T; Niwinski, Rajmund Michal; Beran, Azizullah; Tidwell, Chad; Soubani, Ayman O

Awad, Mohammed T; Niwinski, Rajmund Michal; Beran, Azizullah; Tidwell, Chad; Soubani, Ayman O.

Afiliación

Awad MT; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI.
Niwinski RM; Wayne State University School of Medicine, Detroit, MI.
Beran A; Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN.
Tidwell C; Internal Medicine Department, Wayne State University School of Medicine, Detroit, MI.
Soubani AO; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI.

Am J Ther ; 30(3): e268-e274, 2023 05 01.

Article en En | MEDLINE | ID: mdl-37278708

Asunto(s)

COVID-19; Aspergilosis Pulmonar; Humanos; Enfermedad Crítica/terapia; COVID-19/complicaciones; Tratamiento Farmacológico de COVID-19; Corticoesteroides/efectos adversos; Aspergilosis Pulmonar/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aspergilosis Pulmonar / COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Ther Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google